Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of NovaDerm in burn patients

Next Previous
Trial Profile

Study of NovaDerm in burn patients

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 20 Jan 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 18 Jan 2017 According to a Regenicin media release, companay is planning to Schedule 10 subjects at two burn centers. Grafting will be performed on subjects in this trial in 2017.
  • 01 Nov 2016 According to a Regenicin Inc. media release, the company has completed pre-IND meeting with the FDA Office of Cellular, Tissue, and Gene Therapies (OCTGT) in the Center for Biologics Evaluation and Research (CBER) on October 27th, 2016 regarding NovaDerm.
  • 12 Oct 2016 According to a Regenicin Inc., media release the company has scheduled a Pre-IND meeting with FDA Office on 27th Oct 2016 regarding the development of NovaDerm.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top